Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Cannabidiol

EU orphan designation number: EU/3/17/1959   
Active ingredient: Cannabidiol
Indication: Treatment of tuberous sclerosis
Sponsor: GW Pharma (International) B.V
Databankweg 26, Amersfoort, Utrecht, 3821 AL, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/01/2018 Orphan designation EMA/OD/165/17 (2018)380 of 17/01/2018
12/04/2019 Transfer of orphan designation EMA/OD/0000004767 (2019)2925 of 10/04/2019